Joel G Rurik

6PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 21, 2026
Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis.

Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin

|Mar 10, 2025
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis.

Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin

|Mar 01, 2022
CAR-based therapies: opportunities for immuno-medicine beyond cancer.

Haig Aghajanian, Joel G Rurik, Jonathan A Epstein

|Jan 06, 2022
CAR T cells produced in vivo to treat cardiac injury.

Joel G Rurik, István Tombácz, Amir Yadegari

Pageof 1